Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Other Financing Activities
Financing cash flows not reported separately.
Invesco Ltd.NYSE: IVZ
Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026
Other financing activities turns positive
Q2 FY2026 other financing activities was $34.6M, compared with -$1.14B a year earlier. Trailing-twelve-month other financing activities was $681.6M. Over 3 fiscal years it compounded at -63.5% a year.
Context
- Other financing activities amounted to 0.3% of revenue in FY2025, down 0.5 pp from a year earlier.
- Other financing activities increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other financing activities holds near $34.6M or moves back toward the trailing-twelve-month quarterly average of $170.4M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- 20.6M USD
- Year-over-year change
- +140.3%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20.6M | +140.3% |
| FY2024 | 2024-12-31 | (51.1M) | +6.1% |
| FY2023 | 2023-12-31 | (54.4M) | -112.8% |
| FY2022 | 2022-12-31 | 424.4M | +321.2% |
| FY2021 | 2021-12-31 | (191.9M) | — |
Other Financing Activities vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 other financing activities of $681.6M is the 4th largest of the 11 companies compared; the peer median is $2.98M.
- Its year-over-year change of +155.7% is the 3rd highest of 11, against a peer median of +70.4%.
- Other financing activities amounts to 9.9% of revenue for IVZ, versus a peer median of 6.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $4.25B | +712.0% | — | — | |
| LTM Jun 2026 | $3.12B | +142.5% | +34.6% | 19.9% | |
| LTM Jun 2026 | $1.2B | -39.6% | — | 6.0% | |
| LTM Jun 2026 | $681.6M | +155.7% | -63.5% | 9.9% | |
| LTM Sep 2026 | $512.38M | -2874.1% | — | 20.2% | |
| LTM Sep 2026 | $425.1M | +40.8% | -3.9% | 16.4% | |
| LTM Jun 2026 | $168.1M | -132.4% | — | 2.2% | |
| LTM Jun 2026 | $163.93M | +29437.3% | — | 47.7% | |
| LTM Sep 2026 | $5.95M | -108.4% | — | 0.5% | |
| LTM Mar 2026 | $0 | +100.0% | -31.6% | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding IVZ) | $2.98M | +70.4% | -3.9% | 6.0% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.97B | 925.5M | (96.9M) | 752.4M | (174.8M) |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 140.1M | 106.2M | 114.6M | 104.6M | 80M |
| Change in Working Capital | (294.3M) | (371.5M) | (173M) | 146.2M | (216.4M) |
| Accounts Receivables | 5.58B | 912.8M | 448.7M | 319.7M | (5.6M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (5.88B) | (1.28B) | (621.7M) | (173.5M) | (210.8M) |
| Other Non-Cash Items | (942.4M) | (152.3M) | 1.27B | 7.2M | 1.68B |
| Operating Cash Flow | 1.08B | 703.2M | 1.3B | 1.19B | 1.53B |
| Capital Expenditures | (108.8M) | (192.9M) | (164.3M) | (69.1M) | (84.3M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 236.5M |
| Purchases of Investments | (6.19B) | (2.95B) | (3.26B) | (4.47B) | (5.36B) |
| Sales of Investments | 5.41B | 2.74B | 3.21B | 4.48B | 4.23B |
| Other Investing Activities | 44.9M | 32.6M | (26.8M) | 126.8M | (300K) |
| Investing Cash Flow | (847.9M) | (375.6M) | (244.3M) | 68.4M | (974.4M) |
| Debt Repayment | 914.6M | (575M) | 251.2M | (922.9M) | 2.28B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (60.9M) | (244.7M) | (187.5M) | (79.3M) | (1.86B) |
| Dividends Paid | (544.5M) | (571.6M) | (594.7M) | (608.3M) | (581.9M) |
| Other Financing Activities | (191.9M) | 424.4M | (54.4M) | (51.1M) | 20.6M |
| Financing Cash Flow | 117.3M | (966.9M) | (585.4M) | (1.66B) | (149.5M) |
| Effect of Forex Changes | (39.7M) | (73.7M) | 26.4M | (32.4M) | 82.4M |
| Net Change in Cash | 307.8M | (713M) | 497.5M | (435.6M) | 483.8M |
| Free Cash Flow | 969.3M | 510.3M | 1.14B | 1.12B | 1.44B |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.